Fabian Hoti

5PUBLICATIONS
20CO-AUTHORS
Epidemiological modellingDisease surveillanceInfant and child healthPredictive and prognostic markersMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 13, 2025
Post-authorisation safety study to assess the risk of urinary tract cancer in people with type 2 diabetes initiating empagliflozin: A multi-country European study.

Niklas Schmedt, Ayman Alhamdow, Giorgi Tskhvarashvili

|Aug 26, 2024
Long-Term Safety of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease, a Multinational Observational Database Cohort Study.

Edeltraut Garbe, Fabian Hoti, Tania Schink

|Apr 26, 2023
Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries.

Elena Dudukina, Szimonetta Komjáthiné Szépligeti, Pär Karlsson

|Feb 26, 2019
Pioglitazone use and risk of bladder cancer: a systematic literature review and meta-analysis of observational studies.

Juha Mehtälä, Houssem Khanfir, Dimitri Bennett

|Jan 27, 2018
Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study.

Gunnar Johansson, Vasili Mushnikov, Tobias Bäckström

Pageof 1

Frequent Collaborators

2 joint publications

Laura Saarelainen

2 joint publications

Xu Qiao

1 joint publications

Elena Dudukina

1 joint publications

Pär Karlsson